Annual EBIT
-$19.85 M
+$3.05 M+13.32%
December 31, 2024
Summary
- As of February 27, 2025, NVCT annual earnings before interest & taxes is -$19.85 million, with the most recent change of +$3.05 million (+13.32%) on December 31, 2024.
- During the last 3 years, NVCT annual EBIT has fallen by -$6.95 million (-53.92%).
- NVCT annual EBIT is now -53.92% below its all-time high of -$12.89 million, reached on December 31, 2021.
Performance
NVCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
N/A
December 31, 2024
Summary
- NVCT quarterly earnings before interest & taxes is not available.
Performance
NVCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
N/A
December 31, 2024
Summary
- NVCT TTM earnings before interest & taxes is not available.
Performance
NVCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVCT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.3% | - | - |
| 3 y3 years | -53.9% | - | - |
| 5 y5 years | - | - | - |
NVCT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -53.9% | +13.3% | ||||
| 5 y | 5-year | -53.9% | +13.3% | ||||
| alltime | all time | -53.9% | +13.3% |
Nuvectis Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$19.85 M(-13.3%) | - | - |
| Sep 2024 | - | -$4.36 M(-6.1%) | -$20.26 M(-8.2%) |
| Jun 2024 | - | -$4.64 M(+5.6%) | -$22.06 M(-4.9%) |
| Mar 2024 | - | -$4.40 M(-36.0%) | -$23.19 M(+1.3%) |
| Dec 2023 | -$22.90 M(+19.0%) | -$6.87 M(+11.5%) | -$22.90 M(+0.4%) |
| Sep 2023 | - | -$6.16 M(+6.7%) | -$22.81 M(+1.0%) |
| Jun 2023 | - | -$5.77 M(+40.7%) | -$22.59 M(+10.8%) |
| Mar 2023 | - | -$4.10 M(-39.5%) | -$20.39 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$19.23 M(+49.2%) | -$6.78 M(+14.1%) | -$19.23 M(+30.7%) |
| Sep 2022 | - | -$5.94 M(+66.2%) | -$14.72 M(+9.4%) |
| Jun 2022 | - | -$3.57 M(+21.3%) | -$13.45 M(-15.0%) |
| Mar 2022 | - | -$2.94 M(+30.0%) | -$15.82 M(+22.7%) |
| Dec 2021 | -$12.89 M | -$2.27 M(-51.5%) | -$12.89 M(+21.3%) |
| Sep 2021 | - | -$4.67 M(-21.4%) | -$10.63 M(+78.3%) |
| Jun 2021 | - | -$5.94 M(>+9900.0%) | -$5.96 M(>+9900.0%) |
| Mar 2021 | - | -$23.00 K | -$23.00 K |
FAQ
- What is Nuvectis Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Nuvectis Pharma?
- What is Nuvectis Pharma annual EBIT year-on-year change?
- What is the all time high quarterly EBIT for Nuvectis Pharma?
- What is the all time high TTM EBIT for Nuvectis Pharma?
What is Nuvectis Pharma annual earnings before interest & taxes?
The current annual EBIT of NVCT is -$19.85 M
What is the all time high annual EBIT for Nuvectis Pharma?
Nuvectis Pharma all-time high annual earnings before interest & taxes is -$12.89 M
What is Nuvectis Pharma annual EBIT year-on-year change?
Over the past year, NVCT annual earnings before interest & taxes has changed by +$3.05 M (+13.32%)
What is the all time high quarterly EBIT for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly earnings before interest & taxes is -$23.00 K
What is the all time high TTM EBIT for Nuvectis Pharma?
Nuvectis Pharma all-time high TTM earnings before interest & taxes is -$23.00 K